Simulations Plus, Inc. (NASDAQ:SLP) Q2 2023 Results Earnings Conference Call April 4, 2024 5:00 PM ET
Company Participants
Lisa Fortuna - Investor Relations, Financial Profiles
Shawn O'Connor - Chief Executive Officer
Will Frederick - Chief Financial Officer and Chief Operating Officer
Conference Call Participants
Matthew Hewitt - Craig-Hallum Capital Group
David Larsen - BTIG LLC
François Brisebois - Oppenheimer & Co. Inc.
Operator
Greetings. And welcome to the Simulations Plus Second Quarter Fiscal 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions]. As a reminder, this conference call is being recorded.
It is now my pleasure to introduce Lisa Fortuna from Financial Profiles. Ms. Fortuna, you may now begin.
Lisa Fortuna
Good afternoon, everyone. Welcome to the Simulations Plus second quarter fiscal 2024 financial results conference call.
With me today are Shawn O'Connor, Chief Executive Officer, and Will Frederick, Chief Financial Officer and Chief Operating Officer of Simulations Plus.
Please note that we updated our quarterly earnings presentation, which will serve as a supplement to today's prepared remarks. You can access the presentation on our Investor Relations website at www.simulations-plus.com. After management's commentary, we will open the call for questions.
As a reminder, the information discussed today may include forward-looking statements that involve risks and uncertainties. Words like believe, expect, and anticipate refer to our best estimates as of this call. There can be no assurances that these will actually take place. So, our actual future results could differ significantly from these statements. Further information on the company's risk factors is contained in the company's quarterly and annual reports and filed with the Securities and Exchange Commission.
With that said, I'll now turn the call over to Shawn O'Connor. Shawn?
Shawn O'Connor
Thank you, Lisa. Good afternoon, everyone, and thank you for joining our second quarter fiscal 2024 conference call. Results for the second quarter of fiscal 2024 played out as expected. Our team delivered solid revenue growth of 16%, with strong performance in both our software and services segments and reported diluted earnings per share of $0.20. Given our strong first half results, we are confident we will meet our full year guidance.
Our market continues to show encouraging signs of strength. In the first calendar quarter of 2024, biotech funding has been strong, especially for companies that have drug candidates in the clinic. Biotech companies of this profile can benefit from our full portfolio of modeling and simulation capabilities.